(Q48087117)

English

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Alzheimer's disease

0 references

author name string

Beffert U

1

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Cohn JS

2

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Petit-Turcotte C

3

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Tremblay M

4

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Aumont N

5

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Ramassamy C

6

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Davignon J

7

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Poirier J

8

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

843

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

87-94

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

1-2

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

ApoE associated with lipid has a reduced capacity to inhibit beta-amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Association of human, rat, and rabbit apolipoprotein E with beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901894-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(99)01894-6

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10528114

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48087117&oldid=1385629715"